Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Celanese CorpCE · Entity 3922 | Director | May 09, 2025 | May 13, 2025 |
| GLAUKOS CorpGKOS · Entity 3510 | Director | May 28, 2026 | June 23, 2026 |
| ICU MEDICAL INC/DEICUI · Entity 2385 | Director | May 13, 2026 | May 14, 2026 |
| StepStone Group Inc.STEP · Entity 3755 | Director | September 08, 2026 | September 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Celanese Corp
Report date May 09, 2025 · Filed May 13, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,490 |
Reported balance
After 2025-05-09 transaction · row 1
1 source rowRow 1 · 2025-05-09 · Grant · Acquired 3,376 · Balance 4,490 F1: Annual grant of restricted stock units pursuant to the Company's Amended and Restated 2018 Global Incentive Plan. The restricted stock units vest in full on the one-year anniversary of the date of grant. |
| Common StockSEC Table I · non-derivative | IndirectBy Sentinel Point Partners, Inc. | 50,270 |
Reported balance
Holding disclosure · report date 2025-05-09 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 50,270 |
Filing footnotes · ownership attribution and instrument terms
F1: Annual grant of restricted stock units pursuant to the Company's Amended and Restated 2018 Global Incentive Plan. The restricted stock units vest in full on the one-year anniversary of the date of grant.
GLAUKOS Corp
Report date May 28, 2026 · Filed June 23, 2026 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $106.52 · Expires 2036-05-28 | Direct | 2,987 |
Reported balance
After 2026-05-28 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2026-05-28 · Grant · Acquired 2,987 · Balance 2,987 F1: This Form 4A amends a Form 4 filed June 1, 2026 that incorrectly reported the exercise price of options granted to the Reporting Person on May 28, 2026 as $53.57. The correct exercise price for the options granted is $106.52, as shown above. F2: Granted pursuant to the Issuer's Director Compensation Policy. Vests in full on the one-year anniversary of grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 4A amends a Form 4 filed June 1, 2026 that incorrectly reported the exercise price of options granted to the Reporting Person on May 28, 2026 as $53.57. The correct exercise price for the options granted is $106.52, as shown above.
F2: Granted pursuant to the Issuer's Director Compensation Policy. Vests in full on the one-year anniversary of grant date.
ICU MEDICAL INC/DE
Report date May 13, 2026 · Filed May 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 6,004 |
Reported balance
After 2026-05-13 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-13 · Exercise / conversion · Acquired 1,254 · Balance 6,004 F1: These securities are Restricted Stock Units. |
| Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2026-05-13 | Direct | 0 |
Reported balance
After 2026-05-13 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-13 · Exercise / conversion · Disposed 1,254 · Balance 0 F1: These securities are Restricted Stock Units. F2: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3: These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first. |
| Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2027-05-13 | Direct | 1,475 |
Reported balance
After 2026-05-13 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-05-13 · Grant · Acquired 1,475 · Balance 1,475 F1: These securities are Restricted Stock Units. F2: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3: These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first. |
Filing footnotes · ownership attribution and instrument terms
F1: These securities are Restricted Stock Units.
F2: There is neither a purchase price nor an exercise price for the Restricted Stock Units.
F3: These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first.
StepStone Group Inc.
Report date September 08, 2026 · Filed September 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 19,550 |
Reported balance
After 2026-09-08 transaction · row 1
1 source rowRow 1 · 2026-09-08 · Grant · Acquired 5,616 · Balance 19,550 F1: Represents the number of shares of Class A Common Stock issued to the Reporting Person pursuant to an award of restricted stock units as compensation for the Reporting Person's service on the Issuer's board of directors. The award vests in full on the earlier of the first anniversary of the grant date or the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer. |
| Class A Common StockSEC Table I · non-derivative | IndirectSentinel Point Partners Inc. | 39,536 |
Reported balance
Holding disclosure · report date 2026-09-08 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 39,536 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares of Class A Common Stock issued to the Reporting Person pursuant to an award of restricted stock units as compensation for the Reporting Person's service on the Issuer's board of directors. The award vests in full on the earlier of the first anniversary of the grant date or the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 11, 2021 Filed May 12, 2021 18:55 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 468 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-032003 · doc4.xml · derivative · entry 2 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 468 shares Expires 2021-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first. Read SEC document |
| May 11, 2021 Filed May 12, 2021 18:55 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 468 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-032003 · doc4.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,161 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| April 27, 2021 Filed Apr 29, 2021 20:14 UTC | Celanese Corp CE · Entity 3922 | GrantCommon Stock | 975 | $0.00 | $0.00 |
DisclosureSEC source: 0001306830-21-000112 · wf-form4_161972724471132.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,395 F1 · shares: Annual grant of restricted stock units pursuant to the Company's 2018 Global Incentive Plan. The restricted stock units vest in full on the one-year anniversary of the date of grant. Read SEC document |
| January 04, 2021 Filed Jan 7, 2021 02:29 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 980 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-001752 · a4.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,628 F1 · security: Represents a grant of restricted stock units received by the reporting person in lieu of annual director retainer fees pursuant to a stock-for-fees election under the Issuer's Director Compensation Policy. The units will vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock. F2 · balance_after: Includes 4,880 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| December 15, 2020 Filed Dec 16, 2020 18:58 UTC | StepStone Group Inc. STEP · Entity 3755 | GrantClass A Common Stock | 2,178 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001796022-20-000015 · wf-form4_160814510784419.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,778 F1 · shares: Represents the number of shares of Class A Common Stock issued to the Reporting Person pursuant to an award of restricted stock units as compensation for the Reporting Person's service on the Issuer's board of directors. The award vests in full on the earlier of the first anniversary of the grant date or the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer. F1 · price: Represents the number of shares of Class A Common Stock issued to the Reporting Person pursuant to an award of restricted stock units as compensation for the Reporting Person's service on the Issuer's board of directors. The award vests in full on the earlier of the first anniversary of the grant date or the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| September 18, 2020 Filed Sep 22, 2020 21:25 UTC | StepStone Group Inc. STEP · Entity 3755 | GrantClass A Common Stock | 5,600 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-051518 · doc4.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,600 F1 · kind: Represents the number of shares of Class A Common Stock issued to the Reporting Person pursuant to an award of restricted stock units as compensation for the Reporting Person's service on the Issuer's board of directors. The award vests in full on the earlier of the first anniversary of the grant date or the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer. F1 · price: Represents the number of shares of Class A Common Stock issued to the Reporting Person pursuant to an award of restricted stock units as compensation for the Reporting Person's service on the Issuer's board of directors. The award vests in full on the earlier of the first anniversary of the grant date or the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 03, 2020 Filed Jun 6, 2020 01:33 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 3,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-019059 · form4.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,648 F1 · security: Granted by the Issuer in the form of restricted stock units that vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock. F2 · balance_after: Includes 5,062 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| May 13, 2020 Filed May 14, 2020 19:59 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 1,438 | $0.00 Strike: $181.99 | $0.00 |
DisclosureSEC source: 0001209191-20-029138 · doc4.xml · derivative · entry 4 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,438 Underlying: Common Stock · 1,438 shares Expires 2030-05-13 Read SEC document |
| May 13, 2020 Filed May 14, 2020 19:59 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GrantCommon Stock · Derivative | 468 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-029138 · doc4.xml · derivative · entry 3 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 468 Underlying: Common Stock · 468 shares Expires 2021-05-13 F4 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first. Read SEC document |
| May 13, 2020 Filed May 14, 2020 19:59 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 378 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-029138 · doc4.xml · derivative · entry 2 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 378 shares Expires 2020-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first. Read SEC document |
| May 13, 2020 Filed May 14, 2020 19:59 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 378 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-029138 · doc4.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 693 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 30, 2020 Filed May 4, 2020 20:19 UTC | Celanese Corp CE · Entity 3922 | GrantCommon Stock | 1,849 | $0.00 | $0.00 |
DisclosureSEC source: 0001306830-20-000125 · wf-form4_158862357072770.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,420 F1 · shares: Annual grant of restricted stock units pursuant to the Company's 2018 Global Incentive Plan. The restricted stock units vest in full on the one-year anniversary of the date of grant. Read SEC document |
| January 02, 2020 Filed Jan 3, 2020 21:30 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 1,162 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-000900 · a4.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,748 F1 · security: Represents a grant of restricted stock units received by the reporting person in lieu of annual director retainer fees pursuant to a stock-for-fees election under the Issuer's Director Compensation Policy. The units will vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock. F2 · balance_after: Includes 3,815 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| May 30, 2019 Filed Jun 1, 2019 00:07 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 2,653 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-033245 · a4.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,586 F1 · security: Granted by the Issuer in the form of restricted stock units that vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock. F2 · balance_after: Includes 3,830 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| May 15, 2019 Filed May 16, 2019 16:42 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 1,253 | $0.00 Strike: $225.27 | $0.00 |
DisclosureSEC source: 0001209191-19-030250 · doc4.xml · derivative · entry 4 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,253 Underlying: Common Stock · 1,253 shares Expires 2029-05-15 Read SEC document |
| May 15, 2019 Filed May 16, 2019 16:42 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GrantCommon Stock · Derivative | 378 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-030250 · doc4.xml · derivative · entry 3 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 378 Underlying: Common Stock · 378 shares Expires 2020-05-15 F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award. Read SEC document |
| May 15, 2019 Filed May 16, 2019 16:42 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 315 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-030250 · doc4.xml · derivative · entry 2 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 315 shares Expires 2019-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award. Read SEC document |
| May 15, 2019 Filed May 16, 2019 16:42 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 315 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-030250 · doc4.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 315 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 25, 2019 Filed Apr 29, 2019 20:13 UTC | Celanese Corp CE · Entity 3922 | GrantCommon Stock | 1,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001306830-19-000116 · wf-form4_155656878837344.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,571 F1 · shares: Annual grant of restricted stock units pursuant to the Company's 2018 Global Incentive Plan. The restricted stock units vest in full on the one-year anniversary of the date of grant. Read SEC document |
| January 02, 2019 Filed Jan 16, 2019 21:29 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 1,177 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-19-000318 · primarydocument.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,933 F1 · security: Granted by the Issuer in the form of restricted stock units that vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock. F2 · balance_after: Includes 5,810 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| May 31, 2018 Filed Jun 1, 2018 20:35 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 4,633 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-18-002762 · primarydocument.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,756 F1 · security: Granted by the Issuer in the form of restricted stock units that vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock. F2 · balance_after: Consists of 6,756 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| May 15, 2018 Filed May 17, 2018 21:17 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 1,163 | $0.00 Strike: $269.80 | $0.00 |
DisclosureSEC source: 0001209191-18-031056 · doc4.xml · derivative · entry 2 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,163 Underlying: Common Stock · 1,163 shares Expires 2028-05-15 Read SEC document |
| May 15, 2018 Filed May 17, 2018 21:17 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GrantCommon Stock · Derivative | 315 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-031056 · doc4.xml · derivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 315 Underlying: Common Stock · 315 shares Expires 2019-05-15 F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award. Read SEC document |
| April 20, 2018 Filed Apr 24, 2018 20:40 UTC | Celanese Corp CE · Entity 3922 | GrantSeries A Common Stock | 1,372 | $0.00 | $0.00 |
DisclosureSEC source: 0001306830-18-000123 · wf-form4_152460244548091.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,167 F1 · shares: Annual grant of restricted stock units pursuant to the Company's 2009 Global Incentive Plan, as amended and restated. The restricted stock units vest in full on the one-year anniversary of the date of grant. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 21:45 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 2,123 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-18-000210 · primarydocument.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,123 F1 · security: Represents a grant of restricted stock units received by the reporting person in lieu of annual director retainer fees pursuant to a stock-for-fees election under the Issuer's Director Compensation Policy. The units will vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock. F2 · balance_after: Consists of 2,123 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| December 13, 2017 Filed Dec 14, 2017 23:39 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantStock option (right to buy) · Derivative | 15,000 | $0.00 Strike: $25.77 | $0.00 |
DisclosureSEC source: 0001562180-17-003882 · primarydocument.xml · derivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-12-13 F1 · derivative.exercise_date: Granted pursuant to the Issuer's 2015 Omnibus Incentive Compensation Plan. Vests in full on May 31, 2018. Read SEC document |
| April 20, 2017 Filed Apr 24, 2017 20:35 UTC | Celanese Corp CE · Entity 3922 | GrantSeries A Common Stock | 1,601 | $0.00 | $0.00 |
DisclosureSEC source: 0001306830-17-000140 · wf-form4_149306610011056.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,795 F1 · shares: Annual grant of restricted stock units pursuant to the Company's 2009 Global Incentive Plan, as Amended and Restated February 9, 2017. The restricted stock units vest in full on the one-year anniversary of the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.